Southport Capital Management’s Avanos Medical AVNS Stock Holding History

Southport Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-243	Closed	-$17K	–	188
2018 Q3	$17K	Buy	+243	New	+$15.6K	0.01%	361
2016 Q3	–	Sell	-1,211	Closed	-$39K	–	178
2016 Q2	$39K	Buy	+1,211	New	+$37.1K	0.02%	309

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Southport Capital Management's AVNS Position: Q4 2018 in Review

Southport Capital Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 243 shares — an estimated $17K sold.

Southport Capital Management first reported a position in AVNS in Q2 2016 and held it in 2 quarters. The position peaked at $39K in Q2 2016. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Southport Capital Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
Southport Capital Management sold 243 Avanos Medical shares in Q4 2018, an estimated $17K.
Southport Capital Management first reported a position in Avanos Medical in Q2 2016 and held it in 2 quarters.
Southport Capital Management's Avanos Medical position peaked at $39K in Q2 2016.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.